• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非钙化型导管原位癌的影像学及病理学特征:超声检查能预测升级吗?

Imaging and pathologic features of non-calcified ductal carcinoma in situ: can sonography predict upgrade?

机构信息

Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia.

出版信息

Br J Radiol. 2022 Feb 1;95(1130):20211013. doi: 10.1259/bjr.20211013. Epub 2021 Dec 21.

DOI:10.1259/bjr.20211013
PMID:34870448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8822564/
Abstract

OBJECTIVE

The purpose of this study was to evaluate the imaging and pathologic features and upgrade rate of non-calcified ductal carcinoma (NCDCIS). The study tested the hypothesis that lesions with sonographic findings have higher upgrade rate compared to lesions seen on mammography or MRI only.

METHODS

This retrospective study included patients with ductal carcinoma (DCIS) diagnosed by image-guided core breast biopsy from December 2009 to April 2018. Patients with microcalcifications on mammography or concurrent ipsilateral cancer on core biopsy were excluded. An upgrade was defined as surgical pathology showing microinvasive or invasive cancer.

RESULTS

A total of 71 lesions constituted the study cohort. 62% of cases (44/71) had a mammographic finding, and 38% (27/71) of mammographically occult lesions had findings on either ultrasound, MRI, or both. Of the 67 cases that underwent sonography, a mass was noted in 56/67 (83.6%) cases and no sonographic correlate was identified in 11/67 (16.4%) cases. 21% (15/71) of lesions were upgraded on final surgical pathology. The upgrade rate of patients with sonographic correlate was 27% (15/56) with mammographic findings only was 0% (0/11).

CONCLUSION

DCIS should be considered in the differential diagnosis of architectural distortion, asymmetries, focal asymmetries, and masses, even in the absence of microcalcifications. NCDCIS diagnosed by ultrasound may be an independent risk factor for upgrade.

ADVANCES IN KNOWLEDGE

Radiologists must be aware of imaging features of DCIS and consider increased upgrade rate when NCDCIS is diagnosed by ultrasound.

摘要

目的

本研究旨在评估非钙化性导管癌(NCDCIS)的影像学和病理学特征及升级率。本研究检验了一个假设,即与仅在乳房 X 线摄影或 MRI 上看到的病变相比,具有超声表现的病变具有更高的升级率。

方法

本回顾性研究纳入了 2009 年 12 月至 2018 年 4 月期间经影像引导核心乳腺活检诊断为导管癌(DCIS)的患者。排除了在乳房 X 线摄影上有微钙化或核心活检中同时存在同侧癌症的患者。升级定义为手术病理显示微浸润性或浸润性癌。

结果

共有 71 个病变构成了研究队列。62%的病例(44/71)有乳房 X 线摄影表现,38%(27/71)的乳房 X 线摄影隐匿性病变在超声、MRI 或两者上均有表现。在进行超声检查的 67 例病例中,56/67(83.6%)病例可见肿块,11/67(16.4%)病例未见超声相关表现。最终手术病理有 21%(15/71)的病变升级。有超声相关表现的患者升级率为 27%(15/56),仅存在乳房 X 线摄影表现的患者升级率为 0%(0/11)。

结论

即使没有微钙化,在诊断为结构扭曲、不对称、局灶性不对称和肿块时,也应考虑到 DCIS 的鉴别诊断。通过超声诊断的 NCDCIS 可能是升级的独立危险因素。

知识进步

放射科医生必须了解 DCIS 的影像学特征,并在通过超声诊断 NCDCIS 时考虑到更高的升级率。

相似文献

1
Imaging and pathologic features of non-calcified ductal carcinoma in situ: can sonography predict upgrade?非钙化型导管原位癌的影像学及病理学特征:超声检查能预测升级吗?
Br J Radiol. 2022 Feb 1;95(1130):20211013. doi: 10.1259/bjr.20211013. Epub 2021 Dec 21.
2
Predictors of Invasive Breast Cancer in Patients With Ductal Carcinoma In Situ in Ultrasound-Guided Core Needle Biopsy.超声引导下粗针穿刺活检的导管原位癌患者发生浸润性乳腺癌的预测因素
J Ultrasound Med. 2019 Feb;38(2):481-488. doi: 10.1002/jum.14722. Epub 2018 Aug 1.
3
Breast lesions diagnosed by ultrasound-guided core needle biopsy: Can shearwave elastography predict histologic upgrade after surgery or vaccuum assisted excision?超声引导下粗针穿刺活检诊断的乳腺病变:剪切波弹性成像能否预测手术或真空辅助切除术后的组织学升级?
Clin Imaging. 2018 May-Jun;49:150-155. doi: 10.1016/j.clinimag.2018.03.004. Epub 2018 Mar 3.
4
Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.不典型导管增生:乳腺 DCE-MRI 可用于减少不必要的开放性手术切除。
Eur Radiol. 2020 Jul;30(7):4069-4081. doi: 10.1007/s00330-020-06701-3. Epub 2020 Mar 7.
5
Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy.经典型乳腺小叶肿瘤的核心活检:临床与放射病理相关性研究,随访切除活检。
Mod Pathol. 2013 Jun;26(6):762-71. doi: 10.1038/modpathol.2012.221. Epub 2013 Jan 11.
6
Benign breast papillomas without atypia diagnosed with core needle biopsy: Outcome of surgical excision and imaging follow-up.经核心针活检诊断为非典型性良性乳腺乳头瘤:手术切除和影像学随访的结果。
Eur J Radiol. 2020 Oct;131:109237. doi: 10.1016/j.ejrad.2020.109237. Epub 2020 Aug 28.
7
The risk of upgrade for atypical ductal hyperplasia detected on magnetic resonance imaging-guided biopsy: a study of 100 cases from four academic institutions.磁共振成像引导活检发现的非典型导管增生升级风险:来自四个学术机构的100例研究。
Histopathology. 2016 Apr;68(5):713-21. doi: 10.1111/his.12811. Epub 2015 Oct 5.
8
High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up.MRI引导下真空辅助乳腺活检诊断出的高危病变:影像学特征、手术切除结果或影像学随访
Breast Cancer. 2020 May;27(3):405-414. doi: 10.1007/s12282-019-01032-8. Epub 2019 Dec 14.
9
Predicting Upgrade of Ductal Carcinoma In Situ to Invasive Breast Cancer at Surgery With Ultrafast Imaging.利用超快成像预测导管原位癌在手术中升级为浸润性乳腺癌。
AJR Am J Roentgenol. 2023 Jul;221(1):34-43. doi: 10.2214/AJR.22.28698. Epub 2023 Feb 8.
10
12-year review of MRI-detected breast cancers. How often was a diagnosis of malignancy established using targeted ultrasound and standard 14-gauge core biopsy?12 年的 MRI 检测乳腺癌回顾。使用靶向超声和标准 14 号活检针进行恶性肿瘤诊断的频率是多少?
J Med Imaging Radiat Oncol. 2022 Sep;66(6):738-748. doi: 10.1111/1754-9485.13352. Epub 2021 Nov 26.

本文引用的文献

1
Noncalcified Ductal Carcinoma In Situ (DCIS): Rate and Predictors of Upgrade to Invasive Carcinoma.非钙化导管原位癌(DCIS):升级为浸润性癌的发生率和预测因素。
Acad Radiol. 2021 Mar;28(3):e71-e76. doi: 10.1016/j.acra.2020.02.011. Epub 2020 Mar 26.
2
MR imaging appearance of noncalcified and calcified DCIS.非钙化性和钙化性导管原位癌的磁共振成像表现
Breast J. 2018 May;24(3):343-349. doi: 10.1111/tbj.12948. Epub 2017 Nov 15.
3
The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.4232名女性原位导管癌(DCIS)分级的分布及其对乳腺癌筛查中过度诊断的影响。
Breast Cancer Res. 2016 May 10;18(1):47. doi: 10.1186/s13058-016-0705-5.
4
Correlation between sonographic findings and clinicopathologic and biologic features of pure ductal carcinoma in situ in 691 patients.691例纯导管原位癌的超声检查结果与临床病理及生物学特征的相关性
AJR Am J Roentgenol. 2015 Apr;204(4):878-88. doi: 10.2214/AJR.13.12221.
5
Upgrade of ductal carcinoma in situ on core biopsies to invasive disease at final surgery: a retrospective review across the Scottish Breast Screening Programme.在粗针活检中诊断为导管原位癌,但在最终手术时升级为浸润性疾病:一项针对苏格兰乳腺癌筛查计划的回顾性研究
Clin Radiol. 2015 May;70(5):502-6. doi: 10.1016/j.crad.2014.12.019. Epub 2015 Jan 31.
6
Characteristics associated with upgrading to invasiveness after surgery of a DCIS diagnosed using percutaneous biopsy.经皮穿刺活检诊断为 DCIS 后手术升级为侵袭性的相关特征。
Anticancer Res. 2014 Mar;34(3):1183-91.
7
Ductal carcinoma in situ of the breasts: review of MR imaging features.乳腺导管原位癌:MR 成像特征综述。
Radiographics. 2013 Oct;33(6):1569-88. doi: 10.1148/rg.336125055.
8
US appearance of ductal carcinoma in situ.美国出现的导管原位癌。
Radiographics. 2013 Jan-Feb;33(1):213-28. doi: 10.1148/rg.331125092.
9
Screening-detected calcified and non-calcified ductal carcinoma in situ: differences in the imaging and histopathological features.筛查检出的钙化和非钙化导管原位癌:影像学和组织病理学特征的差异。
Clin Radiol. 2013 Jan;68(1):e27-35. doi: 10.1016/j.crad.2012.09.003. Epub 2012 Nov 22.
10
Sonographic findings of high-grade and non-high-grade ductal carcinoma in situ of the breast.乳腺高级别和非高级别导管原位癌的超声表现。
J Ultrasound Med. 2010 Dec;29(12):1687-97. doi: 10.7863/jum.2010.29.12.1687.